21st
International Conference on Alzheimer’s Drug Discovery

21st International Conference on Alzheimer’s Drug Discovery

This annual conference showcases the innovative approaches of ADDF funded scientists and their newest results. In addition to featuring ADDF's portfolio, the 21st conference program also included guest presentations focused on the latest research in the AD field.

The program featured five sessions:

  1. Novel Approaches for Neuroinflammation
  2. Metabolic and Mitochondrial Approaches for Alzheimer’s Disease
  3. Emerging Areas in Drug Development for Neurodegeneration
  4. Neuroprotection, Synaptic Health and Neurotransmitters
  5. Novel Biomarkers in Alzheimer’s Disease

Review the program and recordings of the guest presentations, panel discussions, virtual posters, and start-up forum pitches at our event page here.

October 5-6, 2020

 

Online Event